Paper23201642
Peptide-based selective inhibitors of matrix metalloproteinase-mediated activities.
Ndinguri MW and 4 others. Molecules, 2012. Cited by 47 papers, by iCite.
Cite this record
ConductScience Library. Peptide-based selective inhibitors of matrix metalloproteinase-mediated activities. Papers, record 23201642. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23201642
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Matrix Metalloproteinase Inhibitors | Major topic |
| Matrix Metalloproteinases | Major topic |
| Peptides | Major topic |
| Binding Sites | |
| Catalytic Domain | |
| Cell Movement | |
| Cell Proliferation | |
| Humans | |
| Protein Conformation | |
| Substrate Specificity | |
| Zinc |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 CA098799 | NCI NIH HHS | United States | R01CA098799 | PubMed and NIH | NIH RePORTER |
| T32 HL007446 | NHLBI NIH HHS | United States | T32HL007446 | PubMed and NIH | NIH RePORTER |
| T32 HL07446 | NHLBI NIH HHS | United States | T32HL007446 | PubMed and NIH | NIH RePORTER |
| CA098799 | NCI NIH HHS | United States | R01CA098799 | PubMed and NIH | NIH RePORTER |
References97
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18238779 | Identification of amino acid residues of the matrix metalloproteinase-2 essential for its selective inhibition by beta-amyloid precursor protein-derived inhibitor. | J Biol Chem | 2008 | https://conductscience.org/library/papers/18238779 | PubMed |
| 2 | 8626782 | The structural basis for the elastolytic activity of the 92-kDa and 72-kDa gelatinases. Role of the fibronectin type II-like repeats. | J Biol Chem | 1996 | https://conductscience.org/library/papers/8626782 | PubMed |
| 3 | 19855192 | A novel and selective membrane type-1 matrix metalloproteinase (MT1-MMP) inhibitor reduces cancer cell motility and tumor growth. | Cancer Biol Ther | 2009 | https://conductscience.org/library/papers/19855192 | PubMed |
| 4 | 14729674 | Distinct roles for the catalytic and hemopexin domains of membrane type 1-matrix metalloproteinase in substrate degradation and cell migration. | J Biol Chem | 2004 | https://conductscience.org/library/papers/14729674 | PubMed |
| 5 | 8120015 | Assessment of the role of the fibronectin-like domain of gelatinase A by analysis of a deletion mutant. | J Biol Chem | 1994 | https://conductscience.org/library/papers/8120015 | PubMed |
| 6 | 17591550 | Chemical design of a radiolabeled gelatinase inhibitor peptide for the imaging of gelatinase activity in tumors. | Nucl Med Biol | 2007 | https://conductscience.org/library/papers/17591550 | PubMed |
| 7 | 21813640 | Structural basis for matrix metalloproteinase-2 (MMP-2)-selective inhibitory action of β-amyloid precursor protein-derived inhibitor. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21813640 | PubMed |
| 8 | 11161720 | MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells. | Exp Cell Res | 2001 | https://conductscience.org/library/papers/11161720 | PubMed |
| 9 | 16707450 | Tight junction protein claudin-1 enhances the invasive activity of oral squamous cell carcinoma cells by promoting cleavage of laminin-5 gamma2 chain via matrix metalloproteinase (MMP)-2 and membrane-type MMP-1. | Cancer Res | 2006 | https://conductscience.org/library/papers/16707450 | PubMed |
| 10 | 22608171 | Functional MMP-9 polymorphisms modulate plasma MMP-9 levels in multiple sclerosis patients. | J Neuroimmunol | 2012 | https://conductscience.org/library/papers/22608171 | PubMed |
| 11 | 21795678 | Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21795678 | PubMed |
| 12 | 21295090 | High-affinity peptide against MT1-MMP for in vivo tumor imaging. | J Control Release | 2011 | https://conductscience.org/library/papers/21295090 | PubMed |
| 13 | 12077439 | Structure of the C-terminally truncated human ProMMP9, a gelatin-binding matrix metalloproteinase. | Acta Crystallogr D Biol Crystallogr | 2002 | https://conductscience.org/library/papers/12077439 | PubMed |
| 14 | 15816516 | Radionuclide imaging of tumor xenografts in mice using a gelatinase-targeting peptide. | Anticancer Res | 2005 | https://conductscience.org/library/papers/15816516 | PubMed |
| 15 | 18048360 | Thrombin induces tumor invasion through the induction and association of matrix metalloproteinase-9 and beta1-integrin on the cell surface. | J Biol Chem | 2008 | https://conductscience.org/library/papers/18048360 | PubMed |
| 16 | 19636064 | Role of leukemia cell invadosome in extramedullary infiltration. | Blood | 2009 | https://conductscience.org/library/papers/19636064 | PubMed |
| 17 | 21193411 | The dimer interface of the membrane type 1 matrix metalloproteinase hemopexin domain: crystal structure and biological functions. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21193411 | PubMed |
| 18 | 21084591 | Metzincin proteases and their inhibitors: foes or friends in nervous system physiology? | J Neurosci | 2010 | https://conductscience.org/library/papers/21084591 | PubMed |
| 19 | 17516913 | Inhibition of MMP-2 gelatinolysis by targeting exodomain-substrate interactions. | Biochem J | 2007 | https://conductscience.org/library/papers/17516913 | PubMed |
| 20 | 21126072 | Peptides from Lactobacillus hydrolysates of bovine milk caseins inhibit prolyl-peptidases of human colon cells. | J Agric Food Chem | 2011 | https://conductscience.org/library/papers/21126072 | PubMed |
Cited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41594666 | Comparison of In Vitro Multiple Physiological Activities of Cys-Tyr-Gly-Ser-Arg (CYGSR) Linear and Cyclic Peptides and Analysis Based on Molecular Docking. | Biomolecules | 2026 | https://conductscience.org/library/papers/41594666 | PubMed |
| 40621756 | Matrix Metalloproteinase-9: A Key Diagnostic Biomarker in Cancer Progression. | Curr Drug Targets | 2025 | https://conductscience.org/library/papers/40621756 | PubMed |
| 40087360 | Computational analysis of antimicrobial peptides targeting key receptors in infection-related cardiovascular diseases: molecular docking and dynamics insights. | Sci Rep | 2025 | https://conductscience.org/library/papers/40087360 | PubMed |
| 39858430 | Targeting Invasion: The Role of MMP-2 and MMP-9 Inhibition in Colorectal Cancer Therapy. | Biomolecules | 2024 | https://conductscience.org/library/papers/39858430 | PubMed |
| 39532649 | Harnessing synergistic effects of MMP-2 Inhibition and bFGF to simultaneously preserve and vascularize cardiac extracellular matrix after myocardial infarction. | Acta Biomater | 2025 | https://conductscience.org/library/papers/39532649 | PubMed |
| 39398382 | Discovery of bioactive peptides as therapeutic agents for skin wound repair. | J Tissue Eng | 2024 | https://conductscience.org/library/papers/39398382 | PubMed |
| 38430575 | Engineering metalloproteinase inhibitors: tissue inhibitors of metalloproteinases or antibodies, that is the question. | Curr Opin Biotechnol | 2024 | https://conductscience.org/library/papers/38430575 | PubMed |
| 38222506 | Short Antiangiogenic MMP-2 Peptide-Decorated Conjugated Linoleic Acid-Coated SPIONs for Targeted Paclitaxel Delivery in an A549 Cell Xenograft Mouse Tumor Model. | ACS Omega | 2024 | https://conductscience.org/library/papers/38222506 | PubMed |
| 37094433 | Identification of small molecule inhibitors against MMP-14 via High-Throughput screening. | Bioorg Med Chem | 2023 | https://conductscience.org/library/papers/37094433 | PubMed |
| 36246349 | Self-assembled peptide-paclitaxel nanoparticles for enhancing therapeutic efficacy in colorectal cancer. | Front Bioeng Biotechnol | 2022 | https://conductscience.org/library/papers/36246349 | PubMed |
| 35068948 | Identifying specific matrix metalloproteinase-2-inhibiting peptides through phage display-based subtractive screening. | Turk J Biol | 2021 | https://conductscience.org/library/papers/35068948 | PubMed |
| 34948082 | Lupinus albus Protein Components Inhibit MMP-2 and MMP-9 Gelatinolytic Activity In Vitro and In Vivo. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34948082 | PubMed |
| 34486249 | Hybrid fusion protein as a dual protease inhibitor for the healing of chronic wounds. | Biotechnol Prog | 2021 | https://conductscience.org/library/papers/34486249 | PubMed |
| 34359533 | An Up-Scalable and Cost-Effective Methodology for Isolating a Polypeptide Matrix Metalloproteinase-9 Inhibitor from Lupinus albus Seeds. | Foods | 2021 | https://conductscience.org/library/papers/34359533 | PubMed |
| 34200889 | Peptides and Peptidomimetics as Inhibitors of Enzymes Involved in Fibrillar Collagen Degradation. | Materials (Basel) | 2021 | https://conductscience.org/library/papers/34200889 | PubMed |
| 33852644 | Changes in gene expression of cervical collagens, metalloproteinases, and tissue inhibitors of metalloproteinases after partial cervical excision-induced preterm labor in mice. | PLoS One | 2021 | https://conductscience.org/library/papers/33852644 | PubMed |
| 32466129 | Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics. | Cells | 2020 | https://conductscience.org/library/papers/32466129 | PubMed |
| 31618886 | Pyridine-Containing Macrocycles Display MMP-2/9 Inhibitory Activity and Distinct Effects on Migration and Invasion of 2D and 3D Breast Cancer Models. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31618886 | PubMed |
| 31140150 | Phage display screening of therapeutic peptide for cancer targeting and therapy. | Protein Cell | 2019 | https://conductscience.org/library/papers/31140150 | PubMed |
| 28969037 | ATIQCTPC targeting MMP-9: a key step to slowing primary tumor growth and inhibiting metastasis of lewis lung carcinoma in vivo. | Oncotarget | 2017 | https://conductscience.org/library/papers/28969037 | PubMed |
Genes30
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23201642
GET https://conductscience.org/api/papers/v1/23201642/references?page=2